Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Fugui Gutong Granules** is an approved oral traditional Chinese medicine granule product developed and manufactured by Dongguan Jinmeiji Pharmaceutical for bone pain, joint pain, and osteoarthritis. Based on the provided company pipeline information, it is described as a classic TCM formula derived from *Jingui Yaolue* and associated with the *Wutou Decoction* tradition, with intended effects framed in TCM terms such as pain relief and improvement of blood stasis. No discrete modern molecular target or validated single-target pharmacology was identified in the provided sources; accordingly, it is best characterized as a marketed multi-component TCM granule for musculoskeletal pain syndromes rather than a target-defined modern therapeutic.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fugui Gutong Granules.